Kasim Kutay

  • Chief executive officer of Novo Holdings A/S.
  • Member of the boards of Novozymes A/S and Evotec SE.
  • Member of the Life Sciences Advisory Board of Gimv NV.

  • Managing director, co-head of Europe and member of the Global Management Committee of Moelis & Co., 2009-2016.
  • Managing director and head of Financial Solutions Group of SUN Group, 2007-2009.
  • Member of the Board of Governors (2006-2011) and the Investment Committee (2011-2016) of the School of Oriental and African Studies (SOAS).
  • Member of the Board of Trustees of Northwick Park Institute for Medical Research, 2005-2016.
  • Positions at Morgan Stanley, including chair of the European Healthcare Group, 1989-2007. 

  • Not considered independent under the Danish Recommendations on Corporate Governance.
  • Member of the Board of Directors since March 2017. Most recently elected in 2021 for a term of one year.
  • Member of the Nomination Committee since March 2017.
  • Member of the Research & Development Committee since March 2020.

  • Global corporate leadership
  • Healthcare and pharma industry
  • Finance & accounting
  • Business development, M&A and external innovation sourcing
  • Human capital management

  • 1987: MSc in Economics, the London School of Economics, UK.
  • 1987: BSc in Economics, the London School of Economics, UK.

UK national, born 1965. Male.